A highly specialized asset management boutique focused on stock investments in selected sectors and regions.
Bellevue Asset Management is the exclusive manager of the Bellevue Funds (Lux) SICAV range of funds and a wholly owned subsidiary of Bellevue Group, an independent, Swiss financial group headquartered in Zurich and listed on the Swiss Exchange SIX.It was established in 1993 and is one of Switzerland’s leading investment boutiques with over EUR 4.6 bn in assets under management.
BB Biotech AG is an investment company listed on the Stoxx Europe 600 with a successful track record that goes back some 20 years. Offering also Luxembourg- and Swiss-based funds with focus on medical technology, biotechnology, generics and healthcare Asia Bellevue is with its assets under management of over CHF 3.5 bn one of the largest European investors in the healthcare space.
Other key offerings are Luxembourg-based investment funds that are focused on structural growth stories in frontier markets like Africa and products that invest specifically in family and entrepreneur owned and run companies listed on the stock market. Bellevue Asset Management ranks among the early pioneers in the management of entrepreneur-themed funds.